Title: DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis.
Journal: PloS one 20130101
Title: Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells.
Journal: Cellular & molecular biology letters 20121201
Title: Zebularine inhibits the growth of HeLa cervical cancer cells via cell cycle arrest and caspase-dependent apoptosis.
Journal: Molecular biology reports 20121001
Title: Flight of a cytidine deaminase complex with an imperfect transition state analogue inhibitor: mass spectrometric evidence for the presence of a trapped water molecule.
Journal: Biochemistry 20120814
Title: Epigenomic silencing of the BMP-4 gene in pituitary adenomas: a potential target for epidrug-induced re-expression.
Journal: Endocrinology 20120801
Title: Promoter methylation and tissue-specific transcription of the α7 nicotinic receptor gene, CHRNA7.
Journal: Journal of molecular neuroscience : MN 20120601
Title: An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: potential therapeutic use in autoimmune diseases.
Journal: Molecular immunology 20120601
Title: The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells.
Journal: International journal of cancer 20120301
Title: Light-regulated and cell-specific methylation of the maize PEPC promoter.
Journal: Journal of experimental botany 20120201
Title: DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.
Journal: Molecular cancer therapeutics 20120201
Title: Mutations in epigenetic modifiers in myeloid malignancies and the prospect of novel epigenetic-targeted therapy.
Journal: Advances in hematology 20120101
Title: Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells.
Journal: Molecular and cellular biochemistry 20120101
Title: Effects of a novel DNA methyltransferase inhibitor Zebularine on human lens epithelial cells.
Journal: Molecular vision 20120101
Title: The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states.
Journal: Molecular pain 20120101
Title: Epigenetic disregulation in oral cancer.
Journal: International journal of molecular sciences 20120101
Title: The influence of cis-regulatory elements on DNA methylation fidelity.
Journal: PloS one 20120101
Title: In planta assays involving epigenetically silenced genes reveal inhibition of cytosine methylation by genistein.
Journal: Plant methods 20120101
Title: DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity.
Journal: Radiation oncology (London, England) 20120101
Title: Epigenetic effects of stress and corticosteroids in the brain.
Journal: Frontiers in cellular neuroscience 20120101
Title: RASSF1A and the Taxol Response in Ovarian Cancer.
Journal: Molecular biology international 20120101
Title: RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?
Journal: Molecular biology international 20120101
Title: Epigenetic dysregulation in laryngeal squamous cell carcinoma.
Journal: Journal of oncology 20120101
Title: Epigenetics modifications and therapeutic prospects in human thyroid cancer.
Journal: Frontiers in endocrinology 20120101
Title: Transgenerational effects of stress exposure on offspring phenotypes in apomictic dandelion.
Journal: PloS one 20120101
Title: Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines.
Journal: PloS one 20120101
Title: Cancer chemoprevention by targeting the epigenome.
Journal: Current drug targets 20111201
Title: Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer.
Journal: Cancer immunology, immunotherapy : CII 20111101
Title: Hypomethylating drugs efficiently decrease cytosine methylation in telomeric DNA and activate telomerase without affecting telomere lengths in tobacco cells.
Journal: Plant molecular biology 20111101
Title: Aberrant DNA methylation and prostate cancer.
Journal: Current genomics 20111101
Title: Genetic rearrangements can modify chromatin features at epialleles.
Journal: PLoS genetics 20111001
Title: Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.
Journal: Hepatology (Baltimore, Md.) 20110902
Title: The structural basis of RNA-catalyzed RNA polymerization.
Journal: Nature structural & molecular biology 20110901
Title: Epigenetic management of major psychosis.
Journal: Clinical epigenetics 20110801
Title: Evolutional and clinical implications of the epigenetic regulation of protein glycosylation.
Journal: Clinical epigenetics 20110801
Title: Insights into mutagenesis using Escherichia coli chromosomal lacZ strains that enable detection of a wide spectrum of mutational events.
Journal: Genetics 20110601
Title: 2´-deoxy-5,6-dihydro-5-azacytidine - a less toxic alternative of 2´-deoxy-5-azacytidine: a comparative study of hypomethylating potential.
Journal: Epigenetics 20110601
Title: 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?
Journal: Toxins 20110601
Title: Dynamic regulation of H3K27 trimethylation during Arabidopsis differentiation.
Journal: PLoS genetics 20110401
Title: MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
Journal: Journal of cancer research and clinical oncology 20110301
Title: Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale.
Journal: Leukemia 20110301
Title: New nucleoside analogs for patients with hematological malignancies.
Journal: Expert opinion on investigational drugs 20110301
Title: Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis.
Journal: Endocrinology 20110201
Title: A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression.
Journal: Journal of the National Cancer Institute 20110105
Title: Effectively incorporating selected multimedia content into medical publications.
Journal: BMC medicine 20110101
Title: Uracil DNA N-glycosylase promotes assembly of human centromere protein A.
Journal: PloS one 20110101
Title: Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth.
Journal: Journal of experimental & clinical cancer research : CR 20110101
Title: Epigenetic regulation of cancer-associated genes in ovarian cancer.
Journal: International journal of molecular sciences 20110101
Title: 5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature.
Journal: Mediterranean journal of hematology and infectious diseases 20110101
Title: Myelodysplastic syndrome and histone deacetylase inhibitors: 'to be or not to be acetylated'?
Journal: Journal of biomedicine & biotechnology 20110101
Title: Epigenetic therapy for breast cancer.
Journal: International journal of molecular sciences 20110101
Title: Generation of reactive oxygen species during apoptosis induced by DNA-damaging agents and/or histone deacetylase inhibitors.
Journal: Oxidative medicine and cellular longevity 20110101
Title: GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells.
Journal: PloS one 20110101
Title: Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2.
Journal: Molecular vision 20110101
Title: Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis.
Journal: PloS one 20110101
Title: Epigenomics of ovarian cancer and its chemoprevention.
Journal: Frontiers in genetics 20110101
Title: Cytosine methyltransferases as tumor markers.
Journal: Current genomics 20101201
Title: Measuring topology of low-intensity DNA methylation sites for high-throughput assessment of epigenetic drug-induced effects in cancer cells.
Journal: Experimental cell research 20101115
Title: DNA methylation regulates cocaine-induced behavioral sensitization in mice.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20101101
Title: Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice.
Journal: The American journal of pathology 20101101
Title: An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer.
Journal: Science translational medicine 20101020
Title: Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A.
Journal: International journal of oncology 20101001
Title: The effect of epigenetic regulation of fucosylation on TRAIL-induced apoptosis.
Journal: Glycoconjugate journal 20101001
Title: Determination of hypersensitivity to genotoxic agents among Escherichia coli single gene knockout mutants.
Journal: DNA repair 20100904
Title: Inhibition of murine DNA methyltransferase Dnmt3a by DNA duplexes containing pyrimidine-2(1H)-one.
Journal: Biochemistry. Biokhimiia 20100901
Title: Clinical advances in hypomethylating agents targeting epigenetic pathways.
Journal: Current cancer drug targets 20100801
Title: Scaling laws for plasma concentrations and tolerable doses of anticancer drugs.
Journal: Cancer research 20100615
Title: Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
Journal: Breast cancer research and treatment 20100401
Title: CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors.
Journal: Breast cancer research and treatment 20100401
Title: Epigenetic approaches to psychiatric disorders.
Journal: Dialogues in clinical neuroscience 20100301
Title: Use of Drosophila deoxynucleoside kinase to study mechanism of toxicity and mutagenicity of deoxycytidine analogs in Escherichia coli.
Journal: DNA repair 20100204
Title: The liver X-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology 20100201
Title: DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine.
Journal: Carcinogenesis 20100201
Title: Cooperation of multiple chromatin modifications can generate unanticipated stability of epigenetic States in Arabidopsis.
Journal: The Plant cell 20100101
Title: A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines.
Journal: PloS one 20100101
Title: Transgenerational adaptation of Arabidopsis to stress requires DNA methylation and the function of Dicer-like proteins.
Journal: PloS one 20100101
Title: Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.
Journal: Journal of translational medicine 20100101
Title: Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Journal: BMC cancer 20100101
Title: Oxidative stress and DNA methylation in prostate cancer.
Journal: Obstetrics and gynecology international 20100101
Title: Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.
Journal: PloS one 20100101
Title: Equitoxic doses of 5-azacytidine and 5-aza-2'deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptome.
Journal: PloS one 20100101
Title: Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds.
Journal: Annals of nutrition & metabolism 20100101
Title: Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation.
Journal: Molecular cancer 20100101
Title: Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.
Journal: Blood 20091224
Title: Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.
Journal: Neoplasia (New York, N.Y.) 20091201
Title: Profiling the repertoire of phenotypes influenced by environmental cues that occur during asexual reproduction.
Journal: Genome research 20091101
Title: DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site.
Journal: Biochemical pharmacology 20090915
Title: Synthesis and conformational analysis of locked carbocyclic analogues of 1,3-diazepinone riboside, a high-affinity cytidine deaminase inhibitor.
Journal: The Journal of organic chemistry 20090821
Title: Methylation of zebularine: a quantum mechanical study incorporating interactive 3D pdf graphs.
Journal: The journal of physical chemistry. B 20090820
Title: CpG methylation controls reactivation of HIV from latency.
Journal: PLoS pathogens 20090801
Title: Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy.
Journal: Current genomics 20090801
Title: Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells.
Journal: Cancer chemotherapy and pharmacology 20090701
Title: The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells.
Journal: Leukemia 20090601
Title: Lasting epigenetic influence of early-life adversity on the BDNF gene.
Journal: Biological psychiatry 20090501
Title: [Recent advances in DNA demethylation in tumor therapy].
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology 20090501
Title: Epigenetic regulation of human buccal mucosa mitochondrial superoxide dismutase gene expression by diet.
Journal: The British journal of nutrition 20090301
Title: Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
Journal: Cancer chemotherapy and pharmacology 20090201
Title: Effective, homogeneous and transient interference with cytosine methylation in plant genomic DNA by zebularine.
Journal: The Plant journal : for cell and molecular biology 20090201
Title: Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition.
Journal: Human molecular genetics 20090115
Title: Transgenerational stress memory is not a general response in Arabidopsis.
Journal: PloS one 20090101
Title: Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205.
Journal: Cancer cell international 20090101
Title: The combination effect of sodium butyrate and 5-Aza-2'-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines.
Journal: World journal of surgical oncology 20090101
Title: Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer.
Journal: BMC medical genomics 20090101
Title: Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.
Journal: Retrovirology 20090101
Title: Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularine.
Journal: Journal of medicinal chemistry 20081211
Title: p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
Journal: Cancer research 20081115
Title: Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20081015
Title: Cancer prevention: epigenetics steps up to the plate.
Journal: Cancer prevention research (Philadelphia, Pa.) 20080901
Title: Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice.
Journal: Cancer prevention research (Philadelphia, Pa.) 20080901
Title: Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells.
Journal: British journal of cancer 20080819
Title: Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.
Journal: Current medicinal chemistry 20080601
Title: Promoter analysis of epigenetically controlled genes in bladder cancer.
Journal: Genes, chromosomes & cancer 20080501
Title: The role of DNA hypermethylation and demethylation in cancer and cancer therapy.
Journal: Current oncology (Toronto, Ont.) 20080401
Title: Incorporation of zebularine from its 2'-deoxyribonucleoside triphosphate derivative and activity as a template-coding nucleobase.
Journal: Nucleosides, nucleotides & nucleic acids 20080201
Title: DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.
Journal: Molecular and cellular biology 20080101
Title: Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer.
Journal: BMC cancer 20080101
Title: The epigenetics of cancer in children.
Journal: Klinische Padiatrie 20080101
Title: Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype.
Journal: Journal of ovarian research 20080101
Title: Zebularine-induced reduction in VEGF secretion by HIF-1α degradation in oral squamous cell carcinoma.
Journal: Molecular medicine reports 20080101
Title: Inhibition of DNA methylation is involved in transdifferentiation of myoblasts into smooth muscle cells.
Journal: Molecules and cells 20071231
Title: Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
Journal: International journal of oncology 20071201
Title: Targeted therapies in the management of metastatic bladder cancer.
Journal: Biologics : targets & therapy 20071201
Title: Low dose Zebularine treatment enhances immunogenicity of tumor cells.
Journal: Cancer letters 20071108
Title: Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines.
Journal: British journal of cancer 20071022
Title: AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
Journal: British journal of haematology 20070901
Title: The Ras-association domain family (RASSF) members and their role in human tumourigenesis.
Journal: Biochimica et biophysica acta 20070901
Title: DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes.
Journal: Molecular pharmacology 20070301
Title: Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.
Journal: Experimental hematology 20070201
Title: Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models.
Journal: Scandinavian journal of gastroenterology 20070101
Title: Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells.
Journal: Molecular cancer 20070101
Title: Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer.
Journal: Molecular cancer 20070101
Title: Clinical implications and utility of field cancerization.
Journal: Cancer cell international 20070101
Title: Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.
Journal: British journal of cancer 20061218
Title: Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications.
Journal: Cancer research 20061115
Title: A mass balance and disposition study of the DNA methyltransferase inhibitor zebularine (NSC 309132) and three of its metabolites in mice.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20061001
Title: Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator.
Journal: Cancer biology & therapy 20060901
Title: Reactivation of p53 function with a demethylating agent.
Journal: Cancer biology & therapy 20060901
Title: DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase 1.
Journal: The Journal of biological chemistry 20060825
Title: p53 expression after treatment with zebularine is not due to demethylation.
Journal: Cancer research 20060701
Title: Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus.
Journal: The Journal of biological chemistry 20060609
Title: Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
Journal: The Prostate 20060515
Title: Transcriptional silencing of multiple genes in trophozoites of Entamoeba histolytica.
Journal: PLoS pathogens 20060501
Title: The role of DNA hypomethylation in the control of stromelysin gene expression.
Journal: Biochemical and biophysical research communications 20060421
Title: Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Journal: Gastroenterology 20060401
Title: Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines.
Journal: Cancer research 20060301
Title: Quantitative determination of zebularine (NSC 309132), a DNA methyltransferase inhibitor, and three metabolites in murine plasma by high-performance liquid chromatography coupled with on-line radioactivity detection.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060202
Title: The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma.
Journal: Blood 20060201
Title: Angiostatic activity of DNA methyltransferase inhibitors.
Journal: Molecular cancer therapeutics 20060201
Title: Epigenetics provides a new generation of oncogenes and tumour-suppressor genes.
Journal: British journal of cancer 20060130
Title: Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.
Journal: Bioorganic & medicinal chemistry 20060101
Title: Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines.
Journal: Cancer cell international 20060101
Title: Hydralazine target: from blood vessels to the epigenome.
Journal: Journal of translational medicine 20060101
Title: Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.
Journal: Annals of the New York Academy of Sciences 20051101
Title: Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
Journal: Molecular cancer therapeutics 20051001
Title: Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Journal: Molecular cancer therapeutics 20051001
Title: Xenopus CENP-A assembly into chromatin requires base excision repair proteins.
Journal: DNA repair 20050712
Title: Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells.
Journal: Biochemical pharmacology 20050701
Title: Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050615
Title: RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
Journal: Nature neuroscience 20050601
Title: Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation.
Journal: Cancer research 20050601
Title: Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050515
Title: Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation.
Journal: Cancer biology & therapy 20050501
Title: Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes.
Journal: The Journal of biological chemistry 20050422
Title: Cancer epigenetics.
Journal: Human molecular genetics 20050415
Title: Origin of tight binding of a near-perfect transition-state analogue by cytidine deaminase: implications for enzyme catalysis.
Journal: Journal of the American Chemical Society 20050309
Title: Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia.
Journal: Anti-cancer drugs 20050301
Title: Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells.
Journal: The Journal of biological chemistry 20050211
Title: Structure of human cytidine deaminase bound to a potent inhibitor.
Journal: Journal of medicinal chemistry 20050210
Title: DNA methylation and cancer therapy: new developments and expectations.
Journal: Current opinion in oncology 20050101
Title: Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology.
Journal: Nucleosides, nucleotides & nucleic acids 20050101
Title: Epigenetics of cervical cancer. An overview and therapeutic perspectives.
Journal: Molecular cancer 20050101
Title: Zebularine: a new drug for epigenetic therapy.
Journal: Biochemical Society transactions 20041201
Title: Three-dimensional structure of the R115E mutant of T4-bacteriophage 2'-deoxycytidylate deaminase.
Journal: Biochemistry 20041102
Title: Zebularine: a candidate for epigenetic cancer therapy.
Journal: Drug discovery today 20041101
Title: The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20041015
Title: Preferential response of cancer cells to zebularine.
Journal: Cancer cell 20040801
Title: Scientists probe shutting down cancer cells by awakening silenced genes.
Journal: JAMA 20040519
Title: Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line.
Journal: Cancer research 20040515
Title: Mutagenicity of the cytidine analog zebularine in Escherichia coli.
Journal: DNA repair 20040203
Title: Synthesis, stability, and protonation studies of a self-complementary dodecamer containing the modified nucleoside 2'-deoxyzebularine.
Journal: Biopolymers 20040101
Title: Potent inhibition of HhaI DNA methylase by the aglycon of 2-(1H)-pyrimidinone riboside (zebularine) at the GCGC recognition domain.
Journal: Annals of the New York Academy of Sciences 20031201
Title: Use of nucleotide analogs by class I and class II CCA-adding enzymes (tRNA nucleotidyltransferase): deciphering the basis for nucleotide selection.
Journal: RNA (New York, N.Y.) 20030801
Title: Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cells.
Journal: The Journal of general virology 20030601
Title: Drug reactivates genes to inhibit cancer.
Journal: Drug discovery today 20030515
Title: Inhibition of DNA methylation and reactivation of silenced genes by zebularine.
Journal: Journal of the National Cancer Institute 20030305
Title: Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases.
Journal: Journal of molecular biology 20020823
Title: Enzymatic conformational fluctuations along the reaction coordinate of cytidine deaminase.
Journal: Protein science : a publication of the Protein Society 20020601
Title: 93rd Annual Meeting of the American Association for Cancer Research, San Francisco, CA, USA, 6-10 April 2002.
Journal: Breast cancer research : BCR 20020101
Title: Champion C, et al. Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine. PLoS One. 2010 Aug 24;5(8):e12388.
Title: Cheng JC, et al. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst. 2003 Mar 5;95(5):399-409.
Title: Billam M, et al. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Breast Cancer Res Treat. 2010 Apr;120(3):581-92.
Title: Lemaire M, et al. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine. Cancer Chemother Pharmacol. 2009 Feb;63(3):411-6.
